What's Affecting Markets Today
ASX Hits Record High as Asia-Pacific Markets Trade Mixed on Wall Street Optimism
Australian equities surged to a fresh record, tracking Wall Street gains driven by strong U.S. economic data and upbeat corporate earnings. The S&P/ASX 200 rose 0.58% in early trade to a record high of 8,689.4, bringing its year-to-date gain to 6.62%, according to LSEG. Index leaders BHP and Rio Tinto advanced 1.7% and 1.32%, respectively, while biotech major CSL rose over 1.7%.
Across the region, sentiment was mixed. China’s CSI 300 edged up 0.27% and Hong Kong’s Hang Seng Index gained 1.28%, led by a 1.73% rise in the Hang Seng Tech Index.
In South Korea, the Kospi has climbed 33.16% year-to-date as legislative reforms bolster investor confidence. A recent revision to the Commercial Act enhances board fiduciary duties, strengthening protection for minority shareholders and lifting long-standing valuation concerns, according to Flashlight Capital Partners.
Taiwan’s TSMC shares rose 2.21% following strong Q2 results. The chipmaker posted a 61% year-on-year profit increase and guided Q3 revenue between $31.8 billion and $33 billion amid robust AI chip demand.
ASX Stocks
ASX 200 8,770.5 (+1.55%)
ASX Surges 1.5% Toward Record Close Amid Broad-Based Rally
The Australian sharemarket is on track for its strongest daily gain since April, as investors return to equities despite stretched valuations. The S&P/ASX 200 advanced 1.5% or 128.7 points to 8767.7 by 2:23pm AEST, eyeing its best session since April 10. The index is up more than 2% this week, nearing its strongest weekly performance since early May.
All 11 sectors are in positive territory, led by healthcare. CSL gained 3.7%, while Mesoblast soared 36.3% to $2.44 on strong commercial uptake of its Ryoncil cell therapy.
BHP climbed 3.3% after reporting record FY25 production of 2.01 million tonnes of copper and 290 million tonnes of iron ore, overcoming early-year cyclone disruptions.
In other corporate news, Fletcher Building rose 3.1% despite flagging ongoing weakness in construction volumes through to 2027. Atlas Arteria slipped 1.1% after a legal setback in Virginia, where it failed to gain approval for a toll hike on the Dulles Greenway. Virgin Australia rose 1.6% after UBS initiated coverage with a ‘Buy’ rating and $3.90 price target.

Leaders
MSB Mesoblast Ltd (+37.99%)
CU6 Clarity Pharmaceuticals Ltd (+10.63%)
PLS Pilbara Minerals Ltd (+9.21%)
LTR Liontown Resources Ltd (+8.33%)
ILU Iluka Resources Ltd (+7.29%)
Laggards
YAL Yancoal Australia Ltd (-6.05%)
DRO Droneshield Ltd (-3.70%)
EDV Endeavour Group Ltd (-2.79%)
WA1 WA1 Resources Ltd (-2.46%)
MPL Medibank Private Ltd (-2.43%)
Join our JTrader Daily Newsletter! Share Trading Made Simple. Rule #1 : Buy stocks that are going UP!
Get our 5 best Stocks that are going Up, sent to your inbox before every trading day!